Proliferation and p53 expression in anal cancer precursor lesions

被引:1
|
作者
Mullerat, J
Deroide, F
Winslet, MC
Perrett, CW
机构
[1] UCL Royal Free & Univ Coll, Sch Med, Dept Surg, London NW3 2QG, England
[2] UCL Royal Free & Univ Coll, Sch Med, Dept Histopathol, London NW3 2QG, England
[3] UCL Royal Free & Univ Coll, Sch Med, Dept Obstet, London NW3 2QG, England
[4] UCL Royal Free & Univ Coll, Sch Med, Dept Gynaecol, London NW3 2QG, England
关键词
AIN; cancer; p53; Ki67;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Anal squamous cell carcinoma (SCC) develops from dysplastic anal warts. This study quantifies the expression of p53 and Ki67 in pre-invasive and invasive anal lesions. Materials and Methods: Samples of 70 patients with anal warts (n=20), low grade anal intraepithelial neoplasia (LG AIN) (n=12), high grade anal intraepithelial neoplasia (HG AIN) (n=27) and anal SCC (n=11) were stained using immunohistochemical techniques. Eight patients with normal anal skin were used as controls. Results: Both the expression of p53 and Ki67 increased significantly (p<0.001) and gradually as the lesions became dysplastic and invasive. The main increase in p53 expression was as the lesions progressed from anal warts (7.38+/-11.93-mean+/-SD) to low grade AIN (20.778+/-13.14). Conclusion: p53 is involved in the progression of anal cancer and its expression increases from early in the development of pre-invasive anal lesions. p53 and Ki67 may be useful markers of early dysplasia and should be considered in the screening of high risk patients.
引用
收藏
页码:2995 / 2999
页数:5
相关论文
共 50 条
  • [31] p53 expression in oral precancer and cancer
    Rich, AM
    Kerdpon, D
    Reade, PC
    AUSTRALIAN DENTAL JOURNAL, 1999, 44 (02) : 103 - 105
  • [32] P53 EXPRESSION IN BREAST-CANCER
    CATTORETTI, G
    RILKE, F
    ANDREOLA, S
    DAMATO, L
    DELIA, D
    INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (02) : 178 - 183
  • [33] P53 EXPRESSION AND DNA-PLOIDY OF CARTILAGE LESIONS
    COUGHLAN, B
    FELIZ, A
    ISHIDA, T
    CZERNIAK, B
    DORFMAN, HD
    HUMAN PATHOLOGY, 1995, 26 (06) : 620 - 624
  • [34] p53 protein expression in benign and malignant breast lesions
    Ioakim-Liossi, A
    Markopoulos, C
    Karakitsos, P
    Safioleas, M
    Gogas, T
    Vaiopoulos, G
    ACTA CYTOLOGICA, 1998, 42 (04) : 918 - 922
  • [35] Expression of p53 in preneoplastic and early neoplastic bronchial lesions
    Martin, B
    Verdebout, JM
    Mascaux, C
    Paesmans, M
    Rouas, G
    Verhest, A
    Ninane, V
    Sculier, JP
    ONCOLOGY REPORTS, 2002, 9 (02) : 223 - 229
  • [36] P53 EXPRESSION AND DNA-PLOIDY OF CARTILAGE LESIONS
    COUGHLAN, B
    FELIZ, I
    ISHIDA, T
    CZERNIAK, B
    DORFMAN, HD
    LABORATORY INVESTIGATION, 1994, 70 (01) : A5 - A5
  • [37] p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer
    Brambilla, E
    Gazzeri, S
    Lantuejoul, S
    Coll, JL
    Moro, D
    Negoescu, A
    Brambilla, C
    CLINICAL CANCER RESEARCH, 1998, 4 (07) : 1609 - 1618
  • [38] The Significance of p16 and p53 Expression on Clinical Outcome in Patients With Anal Cancer Treated at a Single Institution
    Chawla, S.
    Santelli, J.
    Easterly, C.
    Heatherington, B.
    Johnson, N. W. P.
    Turner, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S106 - S106
  • [39] Expression of p185 and p53 in benign and malignant colorectal lesions
    Porcelli, B
    Frosi, B
    Terzuoli, L
    Arezzini, L
    Marinello, E
    Vernillo, R
    De Martino, A
    Vatti, R
    Minacci, C
    HISTOCHEMICAL JOURNAL, 2001, 33 (01): : 51 - 57
  • [40] Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal
    Wong, CS
    Tsao, MS
    Sharma, V
    Chapman, WB
    Pintilie, M
    Cummings, BJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (02): : 309 - 314